Together, these results clearly demonstrate that breast cancer progression is associated with increased serum levels of both OSM and IL-6 and that the serum concentrations of these two cytokines correlate with each other, similar to the results with tumor expression levels of OSM and IL-6. This evidence concerns the gene IL6 and neoplasm.